# Advance Agrolife share price today (Advance Agrolife Ltd, NSE: ADVANCE)

> Advance Agrolife share price today: ₹128.64 at the NSE close on 3 November 2026, down 5.2% in a year. Advance Agrolife (NSE: ADVANCE) is worth ₹827 crore, trades at a P/E of 16.9 and has closed between ₹84.96 and ₹158.43 over the past 52 weeks. > Advance Agrolife Ltd's results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 17% of past readings. ADVANCE · Pesticides/Agrochemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/advance-agrolife-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹128.64 (−5.2% in a year)
- P/E: 16.9× (lower than 83% of the last 1 year)
- Revenue (Jun 2026): ₹330 Cr (+95.3% on a year ago)
- Profit (Jun 2026): ₹23.0 Cr (+155.6% on a year ago)
- Operating margin: 11.0% (+1.0 points on a year ago)
- ROCE: 20%, FY26
- ROIC: 16.6%, against a 12.0% cost of capital: +4.6 points
- Profit that came in as cash: −57%, last 3 years

The main question: profits are rising, but only −57% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Advance Agrolife share price today? Advance Agrolife Ltd's share price was ₹128.64 at the close on 3 November 2026. It has been rising for 11 weeks. That is 9.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹85 and ₹158, and at that close it sat 59% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 18 weeks in a row. Over the last 1 year the share price moved +17% while the NIFTY 500 moved −6%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Advance Agrolife this quarter? Three changes stood out: revenue up on a year earlier for 5 quarters in a row (every quarter we can compare), highest quarterly profit in 9 quarters and highest quarterly revenue in 9 quarters. 1. Revenue up on a year earlier for 5 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹330 crore, +95.3% on a year earlier. 2. Highest quarterly profit in 9 quarters Profit of ₹23 crore in the June 2026 quarter is the highest of the last 9 quarters. 3. Highest quarterly revenue in 9 quarters Revenue of ₹330 crore in the June 2026 quarter is the highest of the last 9 quarters. ## What are Advance Agrolife's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Advance Agrolife reported revenue of ₹330 crore, up 95.3% from ₹169 crore a year earlier, and a profit of ₹23.0 crore, up 155.6% from ₹9.00 crore. ### Advance Agrolife results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹330 crore | ₹169 crore | +95.3% |
| Profit | ₹23.0 crore | ₹9.00 crore | +155.6% |
| Earnings per share | ₹3.51 | ₹1.99 | +76.4% |
| Operating margin | 11.0% | 10.0% | +1.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Advance Agrolife share price history? Advance Agrolife closed at ₹128.64 on 3 November 2026, down 5.2% from ₹135.69 a year earlier (31 October 2025). Its highest weekly close since October 2025 was ₹158.08 on 16 October 2026. ### Advance Agrolife share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹136.43 | −5.7% |
| 1 month ago · 1 Oct 2026 | ₹116.75 | +10.2% |
| 6 months ago · 30 Apr 2026 | ₹110.92 | +16.0% |
| 1 year ago · 31 Oct 2025 | ₹135.69 | −5.2% |
| Earliest weekly close in our records · 10 Oct 2025 | ₹110.27 | +16.7% |
| Highest weekly close since October 2025 · 16 Oct 2026 | ₹158.08 | −18.6% |
| Lowest weekly close since October 2025 · 27 Mar 2026 | ₹92.55 | +39.0% |
| 52-week high (weekly close) · 15 Oct 2026 | ₹158.43 | −18.8% |
| 52-week low (weekly close) · 30 Mar 2026 | ₹84.96 | +51.4% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (60 weekly closes from 10 October 2025 to 3 November 2026.)

## What is the latest news on Advance Agrolife? 3 Nov 2026: Advance Agrolife closed at ₹128.64, down 5.7% on the week and up 10.2% on the month. Results for April to June 2026: Revenue up 95.3% and profit up 155.6% on a year earlier. ## What dividend does Advance Agrolife pay? Advance Agrolife has paid no dividend on the NSE since its first NSE close in our records (10 October 2025), the start of the period we checked. No. Advance Agrolife Ltd paid out 0% of its profit as dividends in each of its last 6 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Advance Agrolife on? Advance Agrolife is not on any of our India lists this week. ## Is Advance Agrolife profitable? Advance Agrolife Ltd earned ₹23.0 Cr of net profit in the Jun 2026 quarter, +155.6% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹35.0 Cr. Over 5 years profit has grown 31.2% a year on average. That is 7.0% of the quarter's revenue. The same quarter a year earlier earned ₹9.0 Cr. For the full year, FY26 profit was ₹35.0 Cr (+34.6% on the year before). Why profit moved: revenue changed +95.3% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +192.5% and revenue +44.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Advance Agrolife make, and is it growing? Advance Agrolife Ltd reported ₹330 Cr of revenue in the Jun 2026 quarter, +95.3% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 5 years it has grown 25.5% a year on average. The last full year, FY26, came in at ₹636 Cr. The last four reported quarters add to ₹800 Cr. FY26 revenue was ₹636 Cr, +28.2% on the year before. Recent pace: the last four quarters grew +44.6% on average, against 25.5% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every ₹100 of sales does Advance Agrolife keep? Advance Agrolife Ltd's operating margin was 11.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 6 years it has been between 6.0% and 10.0%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +0.5 percentage points on the year while gross margin changed −2.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## Is Advance Agrolife's profit turning into cash? Over the last 3 years Advance Agrolife Ltd's operations used more cash than they brought in, so cash conversion was −57%, a gap worth watching. In FY26 its operations used ₹70.0 Cr of cash, against ₹35.0 Cr of profit. After ₹39.0 Cr of spending on assets, free cash was −₹109 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −57% of profit came in as cash: the cash cycle got 28 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 28 days longer. The next section looks at where the cash is stuck. ## Where does Advance Agrolife's cash go? Advance Agrolife Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 110 days in FY26, up from 82 days in FY21. It spent ₹104 Cr on assets over the last 3 years. Customers take 113 days to pay, and stock sits for 154 days on average. At FY26 sales of ₹636 Cr, each day of that cycle ties up about ₹1.7 Cr, so roughly ₹192 Cr is tied up in the business at any time. FY26: customers took 113 days to pay and stock sat for 154 days, about 5.1 months of sales sitting as stock, for a full cycle of 110 days, longer than FY21's 82. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 154 days. Customers pay about 113 days after that. Suppliers are paid at 156 days. Together that makes the 110-day cycle. Spending on assets: ₹104 Cr over the last 3 years, against ₹22.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹22.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Advance Agrolife's P/E ratio, and how does it compare with its own history? Advance Agrolife Ltd's P/E is 16.9×, near the low end of its own history: it has been lower only 17% of the time. Its usual P/E (the middle reading) is 22.2×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹8.67. Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year earnings per share moved −3.7% while the price moved −5.2%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Advance Agrolife business getting better or worse? Advance Agrolife Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 6 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Advance Agrolife earn on its capital? Advance Agrolife Ltd earned a ROCE of 20% in FY26. Its return on capital used (ROIC) is 4.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 5.5% net margin and 1.02× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 5.5% net margin × 1.02× asset turnover × 2.02× leverage (assets divided by equity) ≈ 11.3% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 16.6% − 12.0% = +4.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 16.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 15.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Advance Agrolife have too much debt? Advance Agrolife Ltd has total debt of ₹98.0 Cr against shareholder equity of ₹310 Cr as of Jun 2026, so its debt is 0.32× its equity. Year by year, that ratio went from 0.79 in FY25 to 0.32 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Advance Agrolife shareholding pattern? No group of Advance Agrolife Ltd's owners changed its stake by a full percentage point over the last 4 quarters. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. ## How far is Advance Agrolife from balance-sheet trouble? For Advance Agrolife Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Advance Agrolife rank in its industry? 58.9 out of 100, rank 7 of 25 in Pesticides/Agrochemicals, with 64% of the evidence available. Advance Agrolife Ltd scores 58.9 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 7. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 22.1 + 14.1 + 10.3 + 12.4 = 58.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Advance Agrolife compared with? Advance Agrolife ranks 7 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 58.9 out of 100. 1. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.5/25 · ROCE 30.2% · Operating margin 16% · 100% evidence Valuation 19.2/20 · P/E 9.3× · PEG 0.3 · 100% evidence Relative strength 4.6/20 · Lead over its industry -14.3% · Lead over NIFTY 500 -22.1% · 1 year -23.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.5 + 19.5 + 19.2 + 4.6 = 71.8 · What this means: Earnings are strong; relative strength in its sector is -14.3% and the one-year return is -23.1%. 2. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) turning · Most evidence points up · 83% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.1/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 2 points · 83% evidence Capital efficiency 20.2/25 · ROCE 22.8% · Operating margin 21% · 95% evidence Valuation 5.4/20 · P/E 51.8× · PEG n/a · 50% evidence Relative strength 16.7/20 · Lead over its industry 38.3% · Lead over NIFTY 500 25.1% · 1 year 101.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.1 + 20.2 + 5.4 + 16.7 = 70.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 81% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue -2.8% · Profit 23.8% · Operating margin change 2 points · 88% evidence Capital efficiency 19.6/25 · ROCE 29.1% · Operating margin 20% · 100% evidence Valuation 13.4/20 · P/E 20× · PEG 1.28 · 100% evidence Relative strength 8.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -20.8% · 1 year -33.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 19.6 + 13.4 + 8.6 = 63.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 81% evidence 63.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 8.2% · Profit 43.5% · Operating margin change 1 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.6% · Operating margin 12% · 100% evidence Valuation 15.9/20 · P/E 17.4× · PEG 0.33 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.4% · 1 year -36.4% · 25% evidence · 6 of 12 weeks ahead Exact sum: 24.3 + 13.6 + 15.9 + 9.8 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · losing its lead · Evidence leans up · 81% evidence 63.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 8.7% · Profit 13.2% · Operating margin change 1 points · 88% evidence Capital efficiency 14.7/25 · ROCE 16.8% · Operating margin 15% · 100% evidence Valuation 17.5/20 · P/E 14.3× · PEG 0.38 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 4.7% · 1 year -9.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 14.7 + 17.5 + 12.2 = 63.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans up · 81% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 17% · Profit 10.1% · Operating margin change -2 points · 88% evidence Capital efficiency 15.4/25 · ROCE 16.6% · Operating margin 14% · 100% evidence Valuation 18.2/20 · P/E 12× · PEG 0.36 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -23% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 15.4 + 18.2 + 8.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. Advance Agrolife Ltd this page ADVANCE · breaking out · Evidence leans up · 64% evidence 58.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 48.4% · Profit 81.5% · Operating margin change 1 points · 88% evidence Capital efficiency 14.1/25 · ROCE 19.6% · Operating margin 11% · 100% evidence Valuation 10.3/20 · P/E 16.3× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 10.6% · 1 year -8.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 22.1 + 14.1 + 10.3 + 12.4 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · turning · Evidence leans up · 100% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.8/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.6/25 · ROCE 25.9% · Operating margin 23% · 100% evidence Valuation 9.2/20 · P/E 14.4× · PEG 2.27 · 100% evidence Relative strength 17.4/20 · Lead over its industry 7.1% · Lead over NIFTY 500 -2.8% · 1 year -28.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10.8 + 19.6 + 9.2 + 17.4 = 57 · What this means: Relative strength against the index is -2.8%, and revenue and profit growth are weak. 9. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Evidence leans up · 93% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.6/25 · ROCE 11.4% · Operating margin 15% · 100% evidence Valuation 6.7/20 · P/E 24.7× · PEG 2.26 · 65% evidence Relative strength 8.4/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -11.7% · 1 year -19.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26 + 13.6 + 6.7 + 8.4 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) MOL · breaking out · Evidence leans up · 64% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue -7.8% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 9.5/25 · ROCE 6.7% · Operating margin 18% · 100% evidence Valuation 9.6/20 · P/E 20.8× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.5% · 1 year -35% · 25% evidence · 11 of 12 weeks ahead Exact sum: 22 + 9.5 + 9.6 + 11 = 52.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Too little evidence to rank firmly · 59% evidence 51.0 out of 100 Growth Capital Valuation Relative
12. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 81% evidence 49.6 out of 100 Growth Capital Valuation Relative
13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 48.4 out of 100 Growth Capital Valuation Relative
14. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · quiet · Evidence leans down · 96% evidence 45.3 out of 100 Growth Capital Valuation Relative
15. [Bhagiradha Chemicals & Industries Ltd](https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd) BHAGCHEM · quiet · Evidence leans down · 96% evidence 44.7 out of 100 Growth Capital Valuation Relative
16. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) SHIVALIK · Evidence leans down · 63% evidence 43.9 out of 100 Growth Capital Valuation Relative
17. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) EXCELINDUS · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative
18. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Evidence leans down · 96% evidence 42.0 out of 100 Growth Capital Valuation Relative
19. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans down · 90% evidence 42.0 out of 100 Growth Capital Valuation Relative
20. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 41.7 out of 100 Growth Capital Valuation Relative
21. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 71% evidence 41.5 out of 100 Growth Capital Valuation Relative
22. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 96% evidence 40.5 out of 100 Growth Capital Valuation Relative
23. [P I Industries Ltd](https://www.sectoralpha.in/stocks/p-i-industries-ltd) PIIND · quiet · Evidence leans down · 81% evidence 38.3 out of 100 Growth Capital Valuation Relative
24. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
25. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 76% evidence 29.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to Advance Agrolife in size? Advance Agrolife is the 22nd largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Punjab Chemicals & Crop Protection, Excel Industries and Dharmaj Crop Guard. Just below it: Heranba Industries, Best Agrolife and Shivalik Rasayan. ### Pesticides/Agrochemicals companies close in size

1. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) ₹1,166 crore
2. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) ₹1,074 crore
3. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) ₹862 crore
4. Advance Agrolife Ltd ₹797 crore
5. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) ₹580 crore
6. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) ₹496 crore
7. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) ₹480 crore

[All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies)

### Companies close in size in other industries

1. [Manoj Vaibhav Gems N Jewellers Ltd](https://www.sectoralpha.in/stocks/manoj-vaibhav-gems-n-jewellers-ltd) ₹799 crore · Diamond, Gems & Jewellery
2. [Patel Retail Ltd](https://www.sectoralpha.in/stocks/patel-retail-ltd) ₹799 crore · Trading
3. Advance Agrolife Ltd ₹797 crore
4. [Aryaman Financial Services Ltd](https://www.sectoralpha.in/stocks/aryaman-financial-services-ltd) ₹797 crore · Finance
5. [Indosolar Ltd](https://www.sectoralpha.in/stocks/indosolar-ltd) ₹797 crore · Electric Equipment - General

## What else do people ask about Advance Agrolife? ### What is Advance Agrolife's share price today? Advance Agrolife Ltd's share price is ₹128.64, −5.2% over the past year. The whole company is worth ₹827 Cr on the market. In the last 52 weeks it traded between ₹85 to ₹158; today it is 59% of the way up from the low, 9.2% above its 200-day average (as of 3 November 2026). ### What were Advance Agrolife's latest quarterly results? Advance Agrolife Ltd reported revenue of ₹330 Cr and net profit of ₹23.0 Cr for the Jun 2026 quarter. Revenue rose 95.3% and profit rose 155.6% compared with a year earlier. Earnings per share were ₹3.51. The operating margin was 11.0%, 1.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Advance Agrolife's market cap? Advance Agrolife Ltd's market capitalisation is ₹827 Cr at a share price of ₹128.64. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Advance Agrolife performing? Advance Agrolife Ltd's share price has been rising for 11 weeks. In its latest quarter, revenue rose 95.3% and profit rose 155.6% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 18 weeks running (as of 3 November 2026). ### Will Advance Agrolife's share price go up? This page does not forecast Advance Agrolife Ltd's share price. What it shows instead: the share price is ₹128.64, and it has been rising for 11 weeks. Its P/E of 16.9× is higher than 17% of its own last 1 years (as of 3 November 2026). ### Who owns Advance Agrolife? Promoters own 69.9% of Advance Agrolife Ltd, foreign institutions 4.2%, domestic institutions 2.0% and the public 23.9% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Advance Agrolife in its business cycle? Advance Agrolife Ltd's FY26 operating margin was 10.0%, against a 6-year range of 6.0% to 10.0%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 11.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Advance Agrolife story? The main question: profits are rising, but only −57% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Advance Agrolife a stock worth studying right now? What the numbers show: Advance Agrolife Ltd's results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 17% of past readings. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.